Definitive Contract HHSF223201610081C
Award Date 8/24/16
Potential Completion Date 9/30/18
Potential Value $200K
Federal Agency
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21201, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract was awarded by the Food and Drug Administration (FDA) to the University of Maryland, with a ceiling value of $2,701,214.75. The contract, titled "Genome Sequencing of Diverse Pathogens," is a definitive, firm-fixed-price contract for research and data management services related to genome sequencing. The University of Maryland is the prime contractor, and the contract does not have a set-aside designation. The contract is associated with the University System of...
- The U.S. Food and Drug Administration (FDA) awarded a $159,835 firm fixed price purchase order to the University of Maryland, Baltimore to continue providing high quality infectious disease genomic nucleic acid for the FDA's ARGOS database. This sole source contract, previously held by the University of Maryland since 2015, will support the FDA's need for reference grade microbial sequences through September 2020. The University System of Maryland serves as the parent organization for the...
- This is a $24,500 firm fixed price purchase order awarded by the Department of the Interior US Geological Survey Fort Collins Science Center to the University of Maryland, Baltimore for genome re-sequencing services. The contract does not have a set-aside designation. University of Maryland, Baltimore is a large academic institution and medical center that provides a range of research, healthcare, and education services to federal agencies, including the Department of Health and Human...
- This firm-fixed-price purchase order was awarded by the Northeast Area of a civilian federal agency to the University of Maryland, Baltimore (UMB), a state-controlled institution of higher learning, to process 8 metagenome pooled samples, including quality assessment of metagenomic DNA samples, for a ceiling value of $6,835.00. The award was made without a set-aside designation. UMB, the prime contractor, is a major public research university that frequently receives federal contracts and grants...
- This is a $7,300.00 firm fixed price purchase order awarded by the U.S. Department of Veterans Affairs to the University of Maryland, Baltimore for RNA sequencing, cDNA preparation, PacBio multiplexed Iso-Seq library preparation, PacBio Sequel II sequencing, and delivery of the resulting data sets. The contract has no set-aside designation and the ultimate completion date is February 6, 2020. The University of Maryland, Baltimore is a prominent academic health sciences institution that...
- This is a $29,057,109.85 definitive federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Maryland, Baltimore (UMB) for biomedical research and development. The contract has no set-aside designation. UMB, a major public research university, is the prime contractor and frequently receives federal contracts and grants for its expertise in areas such as medicine, nursing,...
- The Food and Drug Administration awarded a $288,274 firm fixed-price definitive contract to the University of Maryland Baltimore (UMB) on August 27, 2025, with an ultimate completion date of September 29, 2027. This contract supports the Combating Antimicrobial Resistance Bacteria (CARB) Research Program, which identifies and funds research areas where regulatory science can advance new antibacterial drug development by creating innovative drug development tools and standards. The contract is...
- The University of Maryland, Baltimore (UMB) has been awarded a $7,594.08 firm fixed price purchase order contract by the National Institute of Allergy and Infectious Diseases (NIAID) for micro-satellite testing and pyro-sequencing services. UMB, a major public research university, frequently receives federal contracts and grants to support its biomedical and clinical research activities. This contract, which is not set aside, is likely part of a larger research initiative at NIAID, the...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price definitive contract to the University of Maryland, Baltimore (doing business as Baltimore Campus) for research services. The contract has a potential value of $431,746.85 and does not have a set-aside designation. As the parent organization, the University System of Maryland provides institutional support to the University of Maryland, Baltimore. The University of Maryland, Baltimore...
- The University of Maryland, Baltimore (UMB), a child entity within the University System of Maryland, received a $22,000 firm fixed-price purchase order from a civilian federal agency with a Northeast Area designation on August 27, 2015. The contract was awarded without set-aside designation, indicating open competition, with a performance location in Baltimore, Maryland and an ultimate completion date of August 27, 2016. As a comprehensive research and academic health sciences institution,...